The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis

This study is ongoing, but not recruiting participants.

Study NCT00630864 Information provided by FoldRx Pharmaceuticals

First Received: February 27, 2008 Last Updated: February 13, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2010
Estimated Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)